Development and clinical advancement of small molecules for ex vivo expansion of hematopoietic stem cell

Hematopoietic stem cell (HSC) transplantation is the only curative therapy for many diseases. HSCs from umbilical cord blood (UCB) source have many advantages over from bone marrow. However, limited HSC dose in a single CB unit restrict its widespread use. Over the past two decades, ex vivo HSC expa...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jiaxing, Wang, Xiao, Ding, Jiayu, Zhu, Yasheng, Min, Wenjian, Kuang, Wenbing, Yuan, Kai, Sun, Chengliang, Yang, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214065/
https://www.ncbi.nlm.nih.gov/pubmed/35755294
http://dx.doi.org/10.1016/j.apsb.2021.12.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214065/
https://www.ncbi.nlm.nih.gov/pubmed/35755294
http://dx.doi.org/10.1016/j.apsb.2021.12.006

Ejemplares similares